A lab director and other plead guilty to committing medicare fraud.
This is good news for honest pathologists and lab directors. Pathologists need to focus on providing the best diagnosis rather than generating the most revenue.
More on the story is here:
http://www.nj.com/essex/index.ssf/2..._to_taking_bribes_in_parsippany_lab_scam.html
BU Pathology, you seem like a generally decent person, and I respect the fact that you are honest regarding your identity on this board - but I'm calling shenanigans on your comment. You cite a story of someone
clearly committing fraud: accepting "$1,500 each month under a 'sham consulting agreement' to refer blood specimens... The 60-year-old accepted the payments in exchange for filling out a survey that Fischgrund said he knew was only a method to cover up the payouts...". And from that, you conclude that pathologists don't need to focus on generating "the most revenue", just providing the best diagnosis. Seriously? That is a ridiculous, straw-man argument.
I know dozens of honest pathologists running honest labs who are struggling to bring in revenue to support the lab, their employees, and their own salaries in the worsening reimbursement and regulatory environment. Quality of life, independence of physician laboratory operators, and salaries are declining. I'm sure countless people on this board know people in a similar situation, if not themselves. To conclude from the scamster in this article that pathologists shouldn't be concerned about revenue is frankly absurd. Maybe if I were near or at the apex of my career, likely with enough banked to feel comfortable, I'd see it more optimistically. But many of us still have to worry about both providing the best diagnosis and generating revenue. I assume that even you are held accountable for the bottom line of your department, in addition to making sure they provide the best diagnoses.
This is a quintessential example of how pathology leadership is out of touch with what is happening in the field and what pathologists are experiencing. But perhaps this is good news for academic pathologists and lab directors. You need to focus on providing enough federally-subsidized residents and research dollars to support your department rather than being concerned about the future of your field or your trainees.